These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2220603)

  • 41. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haemodynamic, neuroendocrine and metabolic correlates of circulating cytokine concentrations in congestive heart failure.
    Lommi J; Pulkki K; Koskinen P; Näveri H; Leinonen H; Härkönen M; Kupari M
    Eur Heart J; 1997 Oct; 18(10):1620-5. PubMed ID: 9347273
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process?
    Ferrari R; Ceconi C; Curello S; Ferrari F; Confortini R; Pepi P; Visioli O
    Cardiovasc Drugs Ther; 1996 Nov; 10 Suppl 2():623-9. PubMed ID: 9115956
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hemofiltration and the neurohumoral system in patients with severe heart failure].
    Wittels P; Silberbauer K; Glogar DH; Stummvoll HK; Templ H; Kaindl F
    Acta Med Austriaca; 1985; 12(3-4):89-95. PubMed ID: 3911719
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure.
    Packer M; Lee WH; Kessler PD; Gottlieb SS; Bernstein JL; Kukin ML
    Circulation; 1987 May; 75(5 Pt 2):IV80-92. PubMed ID: 2882867
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Activation of neurohumoral systems following acute myocardial infarction.
    Rouleau JL; Moyé LA; de Champlain J; Klein M; Bichet D; Packer M; Dagenais G; Sussex B; Arnold JM; Sestier F
    Am J Cardiol; 1991 Nov; 68(14):80D-86D. PubMed ID: 1684082
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical implications of increased plasma angiotensin II despite ACE inhibitor therapy in patients with congestive heart failure.
    Roig E; Perez-Villa F; Morales M; Jiménez W; Orús J; Heras M; Sanz G
    Eur Heart J; 2000 Jan; 21(1):53-7. PubMed ID: 10610744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
    Schenk S; McCarthy PM; Starling RC; Hoercher KJ; Hail MD; Ootaki Y; Francis GS; Doi K; Young JB; Fukamachi K
    J Thorac Cardiovasc Surg; 2004 Jul; 128(1):38-43. PubMed ID: 15224019
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interaction between atrial natriuretic peptide, renin system and vasopressin in heart failure.
    Riegger AJ
    Eur Heart J; 1990 Apr; 11 Suppl B():79-83. PubMed ID: 2142083
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
    Packer M
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):66-73. PubMed ID: 3037891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neuroendocrinology of congestive heart failure.
    Opie LH
    Cardiovasc J S Afr; 2002; 13(4):171-8. PubMed ID: 12389058
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurohumoral vasoconstrictor systems in heart failure.
    Riegger AJ
    Eur Heart J; 1985 Jun; 6(6):479-89. PubMed ID: 2864248
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of vasopressin in experimental congestive cardiac failure.
    Johnston CI; Arnolda L; Abrahams J; McGrath B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 7():S96-100. PubMed ID: 2434782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Catecholamines: the cardiovascular and neuroendocrine system.
    Ceconi C; Curello S; Ferrari R
    Eur Heart J; 1998 Jun; 19 Suppl F():F2-6. PubMed ID: 9651728
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
    Kasama S; Toyama T; Sumino H; Matsumoto N; Sato Y; Kumakura H; Takayama Y; Ichikawa S; Suzuki T; Kurabayashi M
    J Nucl Med; 2007 Dec; 48(12):1993-2000. PubMed ID: 18006623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroendocrine excitation in heart failure.
    Riegger AJ
    Br Heart J; 1994 Aug; 72(2 Suppl):S28-30. PubMed ID: 7946753
    [No Abstract]   [Full Text] [Related]  

  • 57. [Pathophysiology of left heart failure with reference to hemodynamic and neurohumoral changes].
    Schmieder RE
    Acta Med Austriaca; 1992; 19(3):77-82. PubMed ID: 1357906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effectiveness of converting enzyme inhibition (enalapril) for mild congestive heart failure.
    Kromer EP; Riegger GA; Liebau G; Kochsiek K
    Am J Cardiol; 1986 Feb; 57(6):459-62. PubMed ID: 3004187
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
    Sigurdsson A; Swedberg K
    Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neurohormonal activity in congestive heart failure.
    Kubo SH
    Crit Care Med; 1990 Jan; 18(1 Pt 2):S39-44. PubMed ID: 2136721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.